alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
I 

118TH CONGRESS 

2D SESSION H. R. 7442 

To direct the Comptroller General of the United States to conduct a study 

to assess the feasibility and financial effects of expanding coverage under 

the Medicare program to items and services furnished in the Philippines. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 23, 2024 

Mr. MOYLAN (for himself and Mr. SABLAN) introduced the following bill; 

which was referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of 

such provisions as fall within the jurisdiction of the committee concerned 

A BILL 

To direct the Comptroller General of the United States to 

conduct a study to assess the feasibility and financial 

effects of expanding coverage under the Medicare program to items and services furnished in the Philippines. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Philippine Medicare 

5 Portability Study Act’’. 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•HR 7442 IH

1 SEC. 2. GAO STUDY AND REPORT. 

2 Not later than the date that is 180 days after the 

3 date of the enactment of this Act, the Comptroller General 

4 of the United States shall submit to Congress a report 

5 on the feasibility and financial effects of expanding cov6 erage under the Medicare program under title XVIII of 

7 the Social Security Act (42 U.S.C. 1395 et seq.) to include 

8 items and services furnished in the Philippines to individ9 uals entitled to benefits under part A of such title and 

10 enrolled under part B or part C of such title. Such report 

11 shall include information on the following: 

12 (1) The estimated cost savings to the Medicare 

13 program that would be realized during the period be14 ginning January 1, 2025, and ending December 31, 

15 2034, through payment for such items and services 

16 pursuant to such expansion of coverage, as com17 pared to the likely costs of payment for such items 

18 and services within the United States during such 

19 period. 

20 (2) A description of the legislative and adminis21 trative changes to the Medicare program that would 

22 be required in order for such expansion of coverage 

23 to be implemented. 

Æ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
<PAGE>   1
                                                                  Exhibit 23.1


               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

We consent to the incorporation by reference in the Registration Statement
(Form S-8) pertaining to the 1994 Amended Incentive Stock Plan and 1995 Amended
Director Option Plan of Sequana Therapeutics, Inc. of our report dated February
13, 1997, with respect to the financial statements of Sequana Therapeutics,
Inc. included in its Annual Report (Form 10-K) for the year ended December 31,
1996, filed with the Securities and Exchange Commission.



                                                ERNST & YOUNG LLP


San Diego, California
March 26, 1997
ODP Information Bulletin 

No. 67 February 10, 2003 

TO: All State Administrative Agency Heads

 All State Administrative Agency Points of Contact

FROM: Andrew T. Mitchell

 Acting Director

SUBJECT: Application for the Master of Arts Degree in 

Homeland Defense and Security is Now Available Online

The Office for Domestic Preparedness (ODP) is pleased to announce that the application for admission

to the Master of Arts Degree in Homeland Defense and Security is now available online at the Homeland

Security Leadership Development website at www.hsld.org.

The Master of Arts Degree in Homeland Security is sponsored by the Naval Postgraduate School (NPS)

and ODP. This degree program is designed to improve the capacity of federal, state and local jurisdictions

to plan and execute security measures, which insure the Nation’s capacity to prevent, deter, defeat, and

respond to terrorism. The program will provide future homeland security leaders with the specialized skills

and knowledge needed to meet the challenges of homeland defense and security.

Only federal employees, and government employees of states and localities are eligible for this program.

If you are interested in applying for admission to this master of arts degree program, please visit the

Homeland Security Leadership Development website at www.hsld.org.
I 

118TH CONGRESS 

2D SESSION H. R. 7472 

To designate the facility of the United States Postal Service located at 

835 South 7th Street in Louisville, Kentucky, as the ‘‘Alberta Odell 

Jones Post Office Building’’. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 28, 2024 

Mr. MCGARVEY (for himself and Mr. BARR) introduced the following bill; 

which was referred to the Committee on Oversight and Accountability 

A BILL 

To designate the facility of the United States Postal Service 

located at 835 South 7th Street in Louisville, Kentucky, 

as the ‘‘Alberta Odell Jones Post Office Building’’. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. ALBERTA ODELL JONES POST OFFICE BUILD4 ING. 

5 (a) DESIGNATION.—The facility of the United States 

6 Postal Service located at 835 South 7th Street in Louis7 ville, Kentucky, shall be known and designated as the ‘‘Al8 berta Odell Jones Post Office Building’’. 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•HR 7472 IH

1 (b) REFERENCES.—Any reference in a law, map, reg2 ulation, document, paper, or other record of the United 

3 States to the facility referred to in subsection (a) shall 

4 be deemed to be a reference to the ‘‘Alberta Odell Jones 

5 Post Office Building’’. 

Æ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
§ 520.446 Clindamycin capsules and tablets. ( a ) *Specifications.* ( 1 ) Each capsule contains the equivalent of 25, 75, 150, or 300 milligrams (mg) clindamycin as the hydrochloride salt.
( 2 ) Each tablet contains the equivalent of 25, 75, or 150 mg clindamycin as the hydrochloride salt.
( 3 ) Each capsule contains the equivalent of 25, 75, or 150 mg clindamycin as the hydrochloride salt.
( b ) *Sponsors.* See sponsors in § 510.600(c) of this chapter as follows: ( 1 ) Nos. 054771 and 069043 for use of capsules described in paragraph (a)(1) of this section.
( 2 ) No. 051311 for use of tablets described in paragraph (a)(2) of this section.
( 3 ) No. 043806 for use of tablets described in paragraph (a)(3) of this section.
( c ) *Conditions of use in dogs* — ( 1 ) *Amount.* Wounds, abscesses, and dental infections: 2.5 to 15 mg per pound (/lb) body weight every 12 hours for a maximum of 28 days. Osteomyelitis: 5.0 to 15 mg/lb body weight every 12 hours for a minimum of 28 days.
( 2 ) *Indications for use.* For the treatment of skin infections (wounds and abscesses) due to susceptible strains of coagulase-positive staphylococci (*Staphylococcus aureus* or *S. intermedius*), deep wounds and abscesses due to susceptible strains of *Bacteroides fragilis*, *Prevotella melaninogenicus*, *Fusobacterium necrophorum*, and *Clostridium perfringens*, dental infections due to susceptible strains of *S. aureus*, *B. fragilis*, *P. melaninogenicus*, *F. necrophorum*, and *C. perfringens*, and osteomyelitis due to susceptible strains of *S. aureus*, *B. fragilis*, *P. melaninogenicus*, *F. necrophorum*, and *C. perfringens.*
( 3 ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[67 FR 54954, Aug. 27, 2002, as amended at 68 FR 55824, Sept. 29, 2003; 69 FR 32273, June 9, 2004; 71 FR 39204, July 12, 2006; 73 FR 4077, Jan. 24, 2008; 78 FR 17596, Mar. 22, 2013; 79 FR 28819, May 20, 2014; 80 FR 76386, Dec. 9, 2015; 81 FR 17607, Mar. 30, 2016]
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM HOST
FUNDING INC. FINANCIAL STATEMENTS FOR THE PERIOD ENDING DECEMBER 31, 1996 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                             448
<SECURITIES>                                         0
<RECEIVABLES>                                      223
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                   671
<PP&E>                                          19,405
<DEPRECIATION>                                   (391)
<TOTAL-ASSETS>                                  20,436
<CURRENT-LIABILITIES>                              232
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         7,516
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                    20,436
<SALES>                                          1,540
<TOTAL-REVENUES>                                 1,769
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                 1,238
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 780
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                     (149)
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       149
<EPS-PRIMARY>                                      .12
<EPS-DILUTED>                                      .12


</TABLE>
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Small Business Administration [Disaster Declaration #12049 and #12050]
 AGENCY: U.S. Small Business Administration.
 ACTION: Notice.
 SUMMARY: This is a Notice of the Presidential declaration of a major 
                        ( print page 9006)
                        disaster for Public Assistance Only for the State of Maryland (FEMA-1875-DR), dated 02/19/2010. *Incident:*
                         Severe Winter Storm and Snowstorm. *Incident Period:*
                         12/18/2009 through 12/20/2009.
 DATES: *Effective Date:*
                         02/19/2010. *Physical Loan Application Deadline Date:*
                         04/20/2010. *Economic Injury (EIDL) Loan Application Deadline Date:*
                         11/19/2010.
 ADDRESSES: Submit completed loan applications to: U.S. Small Business Administration, Processing and Disbursement Center, 14925 Kingsport Road, Fort Worth, TX 76155.
 FOR FURTHER INFORMATION CONTACT: A. Escobar, Office of Disaster Assistance, U.S. Small Business Administration, 409 3rd Street, SW., Suite 6050, Washington, DC 20416.


SUPPLEMENTARY INFORMATION: Notice is hereby given that as a result of the President's major disaster declaration on 02/19/2010, Private Non-Profit organizations that provide essential services of governmental nature may file disaster loan applications at the address listed above or other locally announced locations. The following areas have been determined to be adversely affected by the disaster: *Primary Counties:*
                     Baltimore, Caroline, Cecil, Harford, Howard, Kent, Montgomery, Queen Anne's. The Interest Rates are: PercentFor Physical Damage:Non-Profit Organizations With Credit Available Elsewhere
3.625Non-Profit Organizations Without Credit Available Elsewhere
3.000For Economic Injury:Non-Profit Organizations Without Credit Available Elsewhere
3.000
 The number assigned to this disaster for physical damage is 12049B and for economic injury is 12050B. (Catalog of Federal Domestic Assistance Numbers 59002 and 59008) Cynthia G. Pitts, Acting Associate Administrator for Disaster Assistance.


[FR Doc. 2010-3955 Filed 2-25-10; 8:45 am] BILLING CODE 8025-01-P
TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

JUDGMENT RENDERED JUNE 11, 2015

NO. 03-13-00101-CV

Rent-A-Center, Inc., Appellant

v.

Glenn Hegar, in his capacity as Comptroller of Public Accounts of the State of Texas; and 

Ken Paxton, in his capacity as Attorney General of the State of Texas, Appellees

APPEAL FROM 250TH DISTRICT COURT OF TRAVIS COUNTY

BEFORE JUSTICES PURYEAR, GOODWIN, AND FIELD

REVERSED AND REMANDED -- OPINION BY JUSTICE PURYEAR

This is an appeal from the judgment signed by the trial court on January 17, 2013. Having 

reviewed the record and the parties’ arguments, the Court holds that there was reversible error in 

the court’s judgment. Therefore, the Court reverses the trial court’s judgment and remands the 

case to the trial court for a determination of the amount of refund to which appellant is entitled. 

Appellees shall pay all costs relating to this appeal, both in this Court and the court below.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THE FINANCIAL DATA SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED
FROM THE CONDENSED CONSOLIDATED BALANCE SHEETS AND THE CONDENSED STATEMENTS OF
OPERATIONS FOUND ON PAGES F-3 AND F-4 OF THE COMPANY'S FORM 10-K FOR THE TWELVE
MONTHS ENDED JULY 31, 1998, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
SUCH FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                                        <C>
<PERIOD-TYPE>                              12-MOS
<FISCAL-YEAR-END>                          JUL-31-1998
<PERIOD-END>                               JUL-31-1998
<CASH>                                       3,024,028
<SECURITIES>                                         0
<RECEIVABLES>                               54,212,108
<ALLOWANCES>                                 5,262,053
<INVENTORY>                                 72,613,130
<CURRENT-ASSETS>                           133,507,984
<PP&E>                                      23,143,699
<DEPRECIATION>                               5,288,701
<TOTAL-ASSETS>                             167,883,896
<CURRENT-LIABILITIES>                       57,054,096
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         1,000
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>               167,883,896
<SALES>                                    178,102,835
<TOTAL-REVENUES>                           178,102,835
<CGS>                                      116,755,386
<TOTAL-COSTS>                              116,755,386
<OTHER-EXPENSES>                            44,088,681
<LOSS-PROVISION>                             2,173,736
<INTEREST-EXPENSE>                           4,509,897
<INCOME-PRETAX>                             12,991,962
<INCOME-TAX>                                 4,547,187
<INCOME-CONTINUING>                          8,444,775
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 8,444,775
<EPS-PRIMARY>                                     1.30
<EPS-DILUTED>                                     1.19
        

</TABLE>
Exhibit 32



Pursuant to § 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. § 1350)



The undersigned, as the President and Chief Executive Officer, and Interim Chief Financial Officer and Vice President,
Corporate Controller of Exide Technologies, each certify that



(1) the accompanying Quarterly Report on Form 10-Q for the period ended June 30, 2004, fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended;
and



(2) the information contained in the
periodic report fairly presents, in all material respects, the financial condition and results of operations of Exide Technologies at the dates and for the periods indicated.



The foregoing certification is made pursuant to § 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. §1350) and no
purchaser or seller of securities or any other person shall be entitled to rely upon the foregoing certification for any other purpose.



A signed original of this written statement required by Section 906 has been provided to Exide Technologies and will be retained by Exide Technologies and
furnished to the Securities and Exchange Commission or its staff upon request.



The undersigned expressly disclaims any obligation to update the foregoing certification except as required by law.



Date: August 11, 2004



/s/    CRAIG H.
MUHLHAUSERCraig H. Muhlhauser President and Chief Executive Officer/s/    IAN J. HARVIEIan J. Harvie Interim Chief Financial Officer and Vice President, Corporate Controller
[Federal Register Volume 75, Number 36 (Wednesday, February 24, 2010)]
[Notices]
[Pages 8424-8425]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-3709]


-----------------------------------------------------------------------

DEPARTMENT OF STATE

[Public Notice 6903]


Culturally Significant Objects Imported for Exhibition 
Determinations: ``Matisse: Radical Invention 1913-1917''

SUMMARY: Notice is hereby given of the following determinations: 
Pursuant to the authority vested in me by the Act of October 19, 1965 
(79 Stat. 985; 22 U.S.C. 2459), Executive Order 12047 of March 27, 
1978, the Foreign Affairs Reform and Restructuring Act of 1998 (112 
Stat. 2681, et seq.; 22 U.S.C. 6501 note, et seq.), Delegation of 
Authority No. 234 of October 1, 1999, Delegation of Authority No. 236 
of October 19, 1999, as amended, and Delegation of Authority No. 257 of 
April 15, 2003 [68 FR 19875], I hereby determine that the objects to be 
included in the exhibition ``Matisse: Radical Invention 1913-1917,'' 
imported from abroad for temporary exhibition within the United States, 
are of cultural significance. The objects are imported pursuant to loan 
agreements with the foreign owners or custodians. I also determine that 
the exhibition or display of the exhibit objects at the Art Institute 
of Chicago, Chicago, IL, from on or about March 20, 2010, until on or 
about June 20, 2010; at the Museum of Modern Art, New York, NY, from on 
or about July 18, 2010, until on or about October 11, 2010; and at 
possible additional exhibitions or venues yet to be determined, is in 
the national interest. Public Notice of these Determinations is ordered 
to be published in the Federal Register.

FOR FURTHER INFORMATION CONTACT: For further information, including a 
list of the exhibit objects, contact Carol B. Epstein, Attorney-
Adviser, Office of the Legal Adviser, U.S. Department of State 
(telephone: 202/632-6473). The address is U.S. Department of State, SA-
5, L/PD, Fifth Floor, Washington, DC 20522-0505.


[[Page 8425]]


    Dated: February 18, 2010.
Maura M. Pally,
Deputy Assistant Secretary for Professional and Cultural Exchanges, 
Bureau of Educational and Cultural Affairs, Department of State.
[FR Doc. 2010-3709 Filed 2-23-10; 8:45 am]
BILLING CODE 4710-05-P
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7199 Introduced in House (IH)]

<DOC>

118th CONGRESS
  2d Session
                                H. R. 7199

 To designate the facility of the United States Postal Service located 
 at S74w16860 Janesville Road, in Muskego, Wisconsin, as the ``Colonel 
                   Hans Christian Heg Post Office''.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            February 1, 2024

Mr. Fitzgerald (for himself, Mr. Steil, Mr. Tiffany, Mr. Grothman, Mr. 
   Van Orden, Mr. Gallagher, Ms. Moore of Wisconsin, and Mr. Pocan) 
 introduced the following bill; which was referred to the Committee on 
                      Oversight and Accountability

_______________________________________________________________________

                                 A BILL

 
 To designate the facility of the United States Postal Service located 
 at S74w16860 Janesville Road, in Muskego, Wisconsin, as the ``Colonel 
                   Hans Christian Heg Post Office''.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. COLONEL HANS CHRISTIAN HEG POST OFFICE.

    (a) Designation.--The facility of the United States Postal Service 
located S74w16860 Janesville Road in Muskego, Wisconsin, shall be known 
and designated as the ``Colonel Hans Christian Heg Post Office''.
    (b) References.--Any reference in a law, map, regulation, document, 
paper, or other record of the United States to the facility referred to 
in subsection (a) shall be deemed to be a reference to the ``Colonel 
Hans Christian Heg Post Office''.
                                 <all>
```
§ 529.1350 Meloxicam. ( a ) *Specifications.* Each milliliter of solution contains 5 milligrams (mg) meloxicam.
( b ) *Sponsor.* See No. 054771 in § 510.600(c) of this chapter.
( c ) *Conditions of use in dogs* — ( 1 ) *Amount.* Administer 0.1 mg per kilogram of body weight once daily using the metered dose pump.
( 2 ) *Indications for use.* For the control of pain and inflammation associated with osteoarthritis in dogs.
( 3 ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[77 FR 76863, Dec. 31, 2012, as amended at 80 FR 18776, Apr. 8, 2015]
EXHIBIT 32.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

This certification is provided pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and accompanies the Quarterly Report on Form 10-Q (the “Form 10-Q”) for the quarter ended March 31, 2008 of Crimson Exploration Inc. (the “Issuer”).  The undersigned hereby certifies that the Form 10-Q fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)) and that the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Issuer. 

 

| Date:

  | May 14, 2008

                   |   |
|---------------|---------------------------------------|--------|
|          | /s/ Allan D. Keel                     |   |
| Name:         | Allan D. Keel                         |   |
| Title:        | President and Chief Executive Officer |   |
|          |                                  |   |
|          |                                  |   |

 

A signed original of this written statement required by Section 906 has been provided to the Issuer and will be furnished to the Securities and Exchange Commission, or its staff, upon request.